Vertebroplasty Needles Market Report 2026

Vertebroplasty Needles Market Overview

• Vertebroplasty Needles market size has reached to $1.12 billion in 2025 • Expected to grow to $1.95 billion in 2030 at a compound annual growth rate (CAGR) of 11.6% • Growth Driver: Spine Injuries Fueling Growth In Vertebroplasty Needle Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Vertebroplasty Needles Market?

A vertebroplasty needle is a specialized medical instrument used in the minimally invasive surgical procedure known as vertebroplasty. This procedure is typically performed to treat compression fractures in the spine, often caused by osteoporosis or trauma. The needle is used to inject bone cement (usually a type of acrylic resin) directly into the fractured vertebra under imaging guidance, such as fluoroscopy or a computed tomography scan (CT scan), to stabilize the bone and relieve pain. The needle is designed to be precise and minimally traumatic to surrounding tissues during the cement injection process. The main types of vertebroplasty needles are 2.5x100, 2.5x130, 3.2x100, and 3.2x130. A 2.5x100-type vertebroplasty needle refers to a specific type of medical instrument used in vertebroplasty procedures. It encompasses various product types, such as bone cement needles and aspiration needles, for various procedure types, including percutaneous vertebroplasty and kyphoplasty. And it can be distributed through hospital pharmacies, private clinics, retail pharmacies and drug stores, and e-commerce.

What Is The Vertebroplasty Needles Market Growth Forecast?

The vertebroplasty needles market size is expected to see rapid growth in the next few years. It will grow to $1.95 billion in 2030 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to increasing focus on outpatient spine procedures, rising demand for advanced kyphoplasty techniques, growing investments in precision surgical instruments, expansion of aging population globally, technological improvements in cement delivery systems. Major trends in the forecast period include increasing adoption of single-use vertebroplasty needles, rising demand for image-guided cement delivery systems, growing preference for minimally invasive spine procedures, expansion of precision-engineered needle designs, enhanced focus on procedural safety and accuracy.

Global Vertebroplasty Needles Market Segmentation

1) By Product Type: Bone Cement Needles, Aspiration Needles 2) By Needle Size: 2.5x100, 2.5x130, 3.2x100, 3.2x130 3) By Procedure Type: Percutaneous Vertebroplasty, Kyphoplasty Subsegments: 1) By Bone Cement Needles: Straight Bone Cement Needles, Curved Bone Cement Needles 2) By Aspiration Needles: Small Gauge Aspiration Needles, Medium-Gauge Aspiration Needles, Large-Gauge Aspiration Needles

What Are The Drivers Of The Vertebroplasty Needles Market?

An increase in the number of spine injuries is expected to propel the growth of the vertebroplasty needles market going forward. Spine injuries refer to any damage or trauma to the spinal cord, vertebrae, or surrounding tissues, which can result in pain, loss of mobility, or paralysis. Spine injuries are on the rise, driven by factors such as aging populations, increasing participation in sports, and the prevalence of motor vehicle accidents. Vertebroplasty needles are crucial for stabilizing spine injuries by precisely injecting bone cement into fractured vertebrae to alleviate pain and restore vertebral strength. For instance, in May 2024, according to the Spinal Injuries Association, a US-based organization in the field of spinal cord injury care, there were approximately 4,400 new cases of spinal cord injury annually in the UK, translating to someone becoming paralyzed every two hours, leading to an estimated total prevalence of 105,000 spinal cord injuries in 2024. Therefore, an increasing number of spine injuries is driving the vertebroplasty needles industry. The rising healthcare expenditure is expected to propel the growth of the vertebroplasty needles market going forward. Healthcare expenditure refers to the total financial resources spent by individuals, organizations, or governments on preventing, treating, and managing health conditions. Healthcare expenditure is increasing due to advancements in medical technology, as new diagnostic tools, treatments, and innovative therapies often come at higher costs, leading to greater overall spending in healthcare. Rising healthcare expenditure is driving the adoption of advanced minimally invasive procedures, thereby supporting increased demand for vertebroplasty needles used in spinal fracture treatments. For instance, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency responsible for administering the Medicare and Medicaid programs, in 2023, U.S. health care expenditures increased by 7.5%, climbing to $4.9 trillion, or roughly $14,570 for each individual. Therefore, the rising healthcare expenditure is driving the growth of the vertebroplasty needles industry. The growing geriatric population is expected to propel the growth of the vertebroplasty needles market going forward. The geriatric population refers to individuals who are generally 65 years of age or older, and it encompasses the elderly who may experience various health, social, and functional changes due to aging. The growing geriatric population is primarily due to increased life expectancy, as advancements in healthcare and living conditions enable people to live longer. Vertebroplasty needles support the geriatric population by enabling minimally invasive procedures that stabilize osteoporotic vertebral fractures, reduce pain, and improve mobility, thereby enhancing quality of life in elderly patients. For instance, in July 2024, according to the UK Parliament's House of Commons Library, a UK-based government administration, in 2022, there were 12.7 million people aged 65 or older in the UK, representing 19% of the total population. This number is projected to rise to 22.1 million by 2072, accounting for 27% of the population. Therefore, the growing geriatric population is driving growth in the vertebroplasty needles industry.

Key Players In The Global Vertebroplasty Needles Market

Major companies operating in the vertebroplasty needles market are Medtronic plc, Stryker Corporation, DePuy Synthes Inc., Cook Medical LLC, Merit Medical Systems Inc., Globus Medical Inc., Argon Medical Devices Inc., OptiMed GmbH, Tecres S.p.A, Zavation Medical Products LLC, Auxein Medical Pvt Ltd, Captiva Spine Inc., Laurane Medical LLC, Osseon Technologies, Adroit Manufacturing Co., Surtech Medical Inc., TAEYEON Medical Co. Ltd., Teknimed S A SP, Becton Dickinson and Company, BIOPSYBELL S.R.L.

Regional Outlook

North America was the largest region in the vertebroplasty needles market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Vertebroplasty Needles Market?

The vertebroplasty needles market consists of sales of bone cement, cannulas and trocars, injection systems, accessories, and consumables. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.